These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22527229)

  • 21. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lateralized clinical and diffusion-weighted MRI abnormalities in a probable case of sporadic Creutzfeldt-Jakob disease.
    Mourand I; Grandiere-Perez L; Joyes B; Legout A
    Acta Neurol Belg; 2010 Jun; 110(2):193-5. PubMed ID: 20873451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Creutzfeldt-Jakob Disease.
    Narula R; Tinaz S
    N Engl J Med; 2018 Jan; 378(4):e7. PubMed ID: 29365304
    [No Abstract]   [Full Text] [Related]  

  • 24. Prion disease: diagnostic value of cerebrospinal fluid markers.
    Parchi P; Capellari S
    Nat Rev Neurol; 2013 Jan; 9(1):10-1. PubMed ID: 23208112
    [No Abstract]   [Full Text] [Related]  

  • 25. Creutzfeldt-Jakob disease.
    Benninger FF; Steiner I
    JAMA Neurol; 2013 Dec; 70(12):1588-9. PubMed ID: 24322518
    [No Abstract]   [Full Text] [Related]  

  • 26. 14-3-3 {gamma}-isoform detection distinguishes sporadic Creutzfeldt-Jakob disease from other dementias.
    Van Everbroeck BR; Boons J; Cras P
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):100-2. PubMed ID: 15608004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease.
    Castellani RJ; Colucci M; Xie Z; Zou W; Li C; Parchi P; Capellari S; Pastore M; Rahbar MH; Chen SG; Gambetti P
    Neurology; 2004 Aug; 63(3):436-42. PubMed ID: 15304573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease.
    Hamaguchi T; Kitamoto T; Sato T; Mizusawa H; Nakamura Y; Noguchi M; Furukawa Y; Ishida C; Kuji I; Mitani K; Murayama S; Kohriyama T; Katayama S; Yamashita M; Yamamoto T; Udaka F; Kawakami A; Ihara Y; Nishinaka T; Kuroda S; Suzuki N; Shiga Y; Arai H; Maruyama M; Yamada M
    Neurology; 2005 Feb; 64(4):643-8. PubMed ID: 15728285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical presentation of Creutzfeldt-Jakob disease: a rare but important cause of rapidly progressive dementia.
    Taillefer MS; Tangarorang GL; Kuchel GA; Menkes DL
    Conn Med; 2011 Sep; 75(8):473-8. PubMed ID: 21980678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3.
    Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Goebel S; Waniek K; Lachmann I; Zerr I
    J Neurol; 2020 Feb; 267(2):543-550. PubMed ID: 31701333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Creutzfeldt-Jakob disease surveillance in Australia, update to December 2013.
    Klug GM; Boyd A; Sarros S; Stehmann C; Simpson M; McLean CA; Masters CL; Collins SJ
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E348-55. PubMed ID: 25631598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid].
    Brandel JP; Beaudry P; Delasnerie-Lauprêtre N; Laplanche JL
    Rev Neurol (Paris); 1999 Feb; 155(2):148-51. PubMed ID: 10226319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid 14-3-3 protein: variability of sporadic Creutzfeldt-Jakob disease, laboratory standards, and quantitation.
    Aksamit AJ
    Arch Neurol; 2003 Jun; 60(6):803-4. PubMed ID: 12810481
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuronal antibodies in Creutzfeldt-Jakob disease.
    Fujita K; Tanaka K; Takahashi Y
    JAMA Neurol; 2014 Apr; 71(4):514. PubMed ID: 24733267
    [No Abstract]   [Full Text] [Related]  

  • 35. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program.
    Lim JS; Kwon HM; Jang JW; Ju YR; Kim S; Park YH; Park SY; Kim S
    Prion; 2015; 9(2):136-43. PubMed ID: 25996401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuronal antibodies in Creutzfeldt-Jakob disease - reply.
    Graus F; Dalmau J
    JAMA Neurol; 2014 Apr; 71(4):514-5. PubMed ID: 24733268
    [No Abstract]   [Full Text] [Related]  

  • 37. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
    Sanchez-Juan P; Green A; Ladogana A; Cuadrado-Corrales N; Sáanchez-Valle R; Mitrováa E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Bodemer M; Slivarichová D; Saiz A; Calero M; Ingrosso L; Knight R; Janssens AC; van Duijn CM; Zerr I
    Neurology; 2006 Aug; 67(4):637-43. PubMed ID: 16924018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease.
    Karch A; Zerr I
    Neurology; 2013 May; 80(22):2081. PubMed ID: 23713090
    [No Abstract]   [Full Text] [Related]  

  • 39. Magnetic resonance spectroscopy and measurement of tau epitopes of autopsy proven sporadic Creutzfeldt-Jakob disease in a patient with non-specific initial EEG, MRI and negative 14-3-3 immunoblot.
    Sarac H; Hajnsek S; Basić S; Henigsberg N; Rados M; Simić G
    Coll Antropol; 2008 Jan; 32 Suppl 1():199-204. PubMed ID: 18405083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once upon a cataract surgeon.
    Patel RP; Volpi J; Lee AG; Barton JJ
    Surv Ophthalmol; 2012; 57(4):379-85. PubMed ID: 22018677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.